Lumber Liquidators LL Tesla Whitney Tilson K12 Questcor Pharmaceuticals QCOR

Whitney Tilson Announces Another Big Short

From Whitney Tilson via email: RE Opko Health Inc. (NYSE:OPK)

Also see ilson on K12 ‘My response to Dear Whitney – Are we having fun yet?’ and  Whitney Tilson On Why He Loves 3D Systems As a Short

Whitney Tilson

Run, don’t walk, to read this takedown of Opko Health Inc. (NYSE:OPK) (below and attached) – it’s one of the best I’ve ever read.

 

Whitney Tilson K12

Courtesy of Kase Capital

I saw Anthony Bozza of Lakewood Capital present this at the Robin Hood Investors Conference and it was so blindingly obvious that he’s right that, after doing my own work, I shorted it (first at a bit under $10, then more recently as the stock ran up over $11).

 

Bozza is one of the very best short sellers out there and this is the first time he’s ever written publicly.

 

Sent: Wednesday, December 11, 2013 8:38 AM
Subject: OPK Opko Health trading lower; Lakewood Capital reiterates short thesis ($11.50)
Importance: High

 

OPK Opko Health trading lower; Lakewood Capital reiterates short thesis ($11.50)

  • Recall on 21-Nov, shares of OPK traded sharply lower following Lakewood’s presentation of its short thesis at the Robin Hood Investors Conference
  • Today, Lakewood publicly released its analysis on OPK in response to a bullish article by TheStreetSweeper that had been released on 25-Nov in rebuttal to Lakewood’s presentation at the conference.
  • Lakewood believes shares of OPK are worth 75-100% less than where they are currently trading given the company’s history of failures, the low likelihood of meaningful commercial success in any of OPK’s products, the company’s financial performance, and unrealistic bullish analyst forecasts
  • Shares of OPK are currently trading (6.0%) at $10.81

http://seekingalpha.com/article/1887851-opko-health-the-placebo-effect

Full document in pdf Opko Health report-Lakewood Capital-12-11-13

Opko Health Report-Lakewood Capital-12!11!13 by ValueWalk.com

LEAVE A COMMENT


Saved Articles
X
TextTExtLInkTextTExtLInk

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.

Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up for ValueWalkPremium today and get our exclusive content for 35% off.

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 12/31/2019 or after next 25 subscribers take advantage whichever comes first – please do not share this discount with others

 

0